Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04300556
Title A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202, a Folate Receptor Alpha (FR alpha)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Eisai Inc.
Indications

peritoneum cancer

fallopian tube cancer

ovary epithelial cancer

lung adenocarcinoma

endometrial cancer

triple-receptor negative breast cancer

Therapies

MORAb-202

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.